ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers

Strategy reflects Cencora’s commitment to meet customers’ evolving needs

Cencora, a global healthcare company, announced the launch of Accelerate Pharmacy Solutions, a unified portfolio of solutions designed to help hospital and health systems customers optimize operations and improve financial performance.

Accelerate Pharmacy Solutions brings together Cencora’s suite of pharmacy and supply chain solutions, enabling Cencora to deliver an enhanced customer experience and integrated support to address customers’ evolving needs. The solutions range from specialty drug purchasing and cost management strategies to logistics, transport, supply chain and inventory management solutions.

“Healthcare is changing fast, and we recognize the emerging challenges and pressures our customers face today,” said David Tinsley, who was recently appointed SVP and General Manager of Accelerate Pharmacy Solutions. “The development and launch of Accelerate Pharmacy Solutions reflect our commitment to provide our customers with the support and solutions they need to overcome challenges, drive growth and continue to deliver high-quality care.”

A recent report published by the American Hospital Association shows hospitals and health systems continue to face significant pressures, including increasing operational costs.

Cencora partners with hospitals and health systems across the country, ranging from small regional health systems to the nation’s largest specialized providers and sites of care. The design and deployment of Accelerate Pharmacy Solutions aims to help customers:

  • Optimize operations through access to solutions — from inventory storage and tracking to specialized freight solutions — that support a flexible and resilient supply chain.
  • Improve financial performance through bespoke solutions that serve health systems effectively and efficiently, improving insights, connecting data and automating processes.
  • Expand care by leveraging solutions, including pharmacy-to-patient solutions, designed to improve access and outcomes for patients.
  • Safeguard tomorrow through a variety of services, including solutions to ensure reliable and consistent access to critical therapies.

“We work closely with our customers to understand their operational, financial and strategic priorities, and then deliver support – or tailor solutions — to help them achieve those goals,” said Matt Glucksmann, SVP & President, Health System and Government Services, Cencora. “As our customers navigate a rapidly changing healthcare landscape, we’re focused on solving their most critical problems through meaningful partnership, industry-leading technology and expert advice with the goal of creating better experiences and outcomes for their pharmacy and patients.”

For more information on Accelerate Pharmacy Solutions, visit here. Leaders from Cencora will also be at ASHP Midyear’s Clinical Meeting & Exhibition on Dec. 8 – 12 in New Orleans. Conference attendees interested in learning more can visit Cencora’s booth (No. 547).

About Cencora

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than $250 billion in annual revenue. Learn more at www.cencora.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.